Journal article
Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy
C Spurney, R Shimizu, LP Morgenroth, H Kolski, H Gordish-Dressman, PR Clemens, M Cregan, E Goude, M Glick, L Johnson, J Han, N Joyce, D Kilmer, A Nicorici, C Chidambaranathan, S Kumar, L Eliasoph, E Hosaki, A Gonzales, V Harris Show all
Muscle and Nerve | Published : 2014
DOI: 10.1002/mus.24163
Abstract
Introduction: Cardiomyopathy is a common cause of morbidity and death in patients with Duchenne muscular dystrophy (DMD). Methods: This investigation was a cross-sectional cross-sectional analysis of clinical data from the multi-institutional Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study of 340 DMD patients aged 2-28 years. Cardiomyopathy was defined as shortening fraction (SF) <28% or ejection fraction (EF) 0.68). In patients with cardiomyopathy, 57% (27 of 47) reported not taking any cardiac medications. Cardiac medications were used in 12% (15 of 127) of patients without cardiomyopathy. Conclusions: We found that echocardiograms were underutilize..
View full abstractGrants
Awarded by National Center for Research Resources
Funding Acknowledgements
This project was funded through grants from the U.S. Department of Education/NIDRR (#H133B031118, #H133B090001), the NIH/NINDS Paul D. Wellstone Muscular Dystrophy Research Centers (U54HD053177), the U.S. Department of Defense (#W81XWH-09-1-0592) and NIH/NCRR (#UL1RR031988).